Skip to content

Clinical trials

Active, not recruiting Carcinoma, Non-Small-Cell Lung trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Active, not recruiting Country / region: Australia Clear all

85 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20131
20153
20162
20176
20183
20197
202010
20219
202215
202316
20249
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting85

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca11
Eli Lilly and Company6
AbbVie5
Hoffmann-La Roche5
Merck Sharp & Dohme LLC5
Janssen Research & Development, LLC4
Bristol-Myers Squibb3
Daiichi Sankyo3
Novartis Pharmaceuticals3
Amgen2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung85
Colorectal Neoplasms15
Neoplasms13
Lung Neoplasms12
Neoplasm Metastasis12
Ovarian Neoplasms11
Stomach Neoplasms10
Carcinoma, Renal Cell9
Pancreatic Neoplasms9
Endometrial Neoplasms8

Trials

Showing 1 to 25 of 85. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.